Tumor necrosis factor-alpha in isolated perfusion systems in the treatment of cancer: the Rotterdam preclinical-clinical program
SourceSeminars in Surgical Oncology, 14, (1998), pp. 232-237
Article / Letter to editor
Display more detailsDisplay less details
Seminars in Surgical Oncology
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.